President sold 200,000 shares

Quote

anonymous

Guest
President Robert Rosen sold 200,000 shares of Heron Therapeutics stock in a transaction on Thursday, April 21st. The stock was sold at an average price of $23.23, for a total value of $4,646,000.00. Following the sale, the president now directly owns 178,968 shares of the company’s stock, valued at $4,157,426.64.
 












Net income of Negative 33.45 million this period compared to a net income of Negative 31.24 million last period. This is a growth of Negative7.05% over the previous period. Losing money and momentum.
 






His Compensation....he should not be complaining Over 4 million this year

Total Annual Compensation, USD 540,750

All Other, USD 3,578,580
Fiscal Year Total, USD 4,119,330
 
























Heron's stock price has dropped 33% this year as the Sustol delay drags on. Investors are already discounting the drug's commercial potential. Rosen knows it is a loser
 


















He is a complete joke. Only cares about himself and terrible leader. I worked with him years ago and it seems like nothing has changed. Heron will not make it with Rob on board. He will be fired if his track record holds up.
 












Top Bottom
Back
Quote